期刊文献+

亚胺培南诱导常见革兰阴性杆菌产生AmpC酶的研究 被引量:3

Study on production of AmpCs induced by imipenem in common Gram negative bacilli.
在线阅读 下载PDF
导出
摘要 目的:了解亚胺培南对鲍氏不动杆菌,阴沟肠杆菌、铜绿假单胞菌、以及产ESBLs的大肠埃希菌和肺炎克雷伯菌等常见革兰阴性杆菌透导性AmpC酶的发生率。方法:采用底物协同—拮抗法(MSSAT)检测大肠埃希菌,肺炎克雷伯菌,铜绿假单胞菌,鲍氏不动杆菌和阴沟肠杆菌产AmpC酶的情况及构成。结果:产ES- gLs的大肠埃希菌和肺炎克雷伯菌、铜绿假单胞菌、阴沟肠杆菌、鲍氏不动杆菌AmpCs酶的检出率分别为20.7%,23.1%,76%,75%,87.9%;高诱导型AmpC酶的检出率分别为0,15.4%,44%,35%,9.1%;部分去阻遏型AmpC酶的检出率分别为3.5%,7.7%,16%,30%,15.2%;完全去阻遏型AmpC酶的检出率分别为17.2%,0%,16%,10%,63.6%。结论:亚胺培南对铜绿假单胞菌和阴沟肠杆菌产AmpC酶具有高度诱导性,而对产ESBLs大肠埃希菌和肺炎克雷伯菌及鲍氏不动杆菌诱导性低,应引起临床和实验室的重视;AmpC酶的诱导表型与菌株的耐药程度相关。 Objective:To investigate the production of AmpCs induced by imipenem in common gram negative bacilli such as Acinetobacter sp,E.cloacae,P.aeruginosa,and ESBLs produducing strains including E.coli and K.pneumonia.Methods:The production of AmoCs strains of E.coli,K.pneumoniae Acinetobacter,E.cloacae, P.aeruginosa were detected with muti substrates synergy-antagonize test (MSSAT).Results:The positive rates of AmpCs in P.aeruginosa,Acinetobacter,E.cloacae,E.coli and K.pneumonia were 20.7%,23.1%,76%, 75% and 87.9%,respectively.The positive rates of highly inducible AmpCs were 0,15.4%,44%,35% and 9. 1%,respectively.The positive rates of partially derepressed Ampcs were 3.5%,7.7%,16%,30% and 15.2%, respectively.The detecting rates of stably derepressed Ampcs were 17.2%,0,16%,10%,and 63.6%,respec- tively.Conclusion:The results suggested that imipenem showed highly inducible effect for AmpC in E.cloacae and P.aeruginosa,but weak effect in E.coli,K.pneumoniae and Acinetobacter,and the AmpCs inducible phe- nocopy of strains were related to antimimicrobial resistance.This phenomenon should to be appreciated by labora- tory and clinical worker.
出处 《感染.炎症.修复》 2005年第4期216-218,共3页 Infection Inflammation Repair
关键词 亚胺培南 Β内酰胺酶 部分去阻遏 完全去阻遏 高诱导 AmpCs Imipenem β-Lactamases Partially derepressed Stably derepressed Highly inducible AmpCs
  • 相关文献

参考文献6

二级参考文献80

  • 1徐英春,陈民钧.AmpC酶与革兰阴性菌的耐药特征[J].中华微生物学和免疫学杂志,2001,21(S1):18-20. 被引量:24
  • 2彭奕冰,朱月秋,季育华,倪语星.革兰阴性杆菌中产AmpC酶菌株的药敏谱分析[J].中华微生物学和免疫学杂志,2001,21(S1):73-74. 被引量:1
  • 3Thomson ES, Sanders CC, Moland ES. Use of microdilution panels with and without β-Lactamase Inhibitors as a phenotypic test for β-Lactamase production among Escherichia coli, Klebsiella spp,Enterobacter spp,Citrobacter freundii, and Seratia marcesens. Antimicrob Agents chemother,1999;43(6):1393~400.
  • 4National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing. Ninth informational supplement M100-S9. Wayne Pennsylvania:National Committee for Clinical Laboratory Standards, 1999;19:36~75.
  • 5Tzelepi E, Giakkoupi P, Sofianou D et al. Detection of extendde-spectrum-β-lactamases in clinical isolates of enterobacter cloacae and enterobacter aerogenes. J Clin Microbiol,2000;38(2):542~6.
  • 6Pitout J D, Sanders C C, Sanders W E Jr. Antimicrobial resistance with focus on β-lactam resistance in Gram-negative bacilli [J]. Am J Med, 1997, 103(1): 51-59.
  • 7Lister P D, Gardner V M, Sanders C C. Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin. [J]. Antimicrob Agent Chemother, 1999, 43(4): 882-889.
  • 8Bennett P M, Chopra I. Molecular basis of β-lactamase induction in bacterial [J]. Antimicrob Agent Chemother, 1993, 37(2): 153-158.
  • 9Coudron P E, Moland E S, Thomoson K S. Occurrence and detection of AmpC beta- lactamases among Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis isolates at a veterans medical center [J]. J Clin Microbiol, 2000, 38(5): 1791-1796.
  • 10Takahashi A, Yomoda S, Kobayashi I, et al. Detection of carbapenemase-producing Acinetobacter baumannii in a hospital[J]. J Clin Microbiol, 2000, 38(2): 526-529.

共引文献183

同被引文献25

  • 1周立新,张秀平,方滨,李轶男,誉铁鸥,毛克江,苏艳玲.重症监护病房感染患者铜绿假单胞菌的分离与耐药性分析[J].中华医院感染学杂志,2004,14(7):807-808. 被引量:61
  • 2李华茵,何礼贤,胡必杰,王葆青,陈雪华.重症监护病房呼吸机相关肺炎临床与病原学分析[J].中国呼吸与危重监护杂志,2005,4(4):266-270. 被引量:69
  • 3周洁.盆腔脓肿的临床特点及误诊分析[J].中国基层医药,2006,13(2):305-307. 被引量:10
  • 4Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med, 2002,165 : 867-903.
  • 5Rosenthal VD, Guzman S, Orellano PW. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. Am J Infect Control, 2003,31 : 291-295.
  • 6Porzecanski I, Bowton DL. Diagnosis and treatment of ventilator-associated pneumonia. Chest, 2006,130: 597-604.
  • 7Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev, 2006,19 : 637-657.
  • 8Kollef MH. Appropriate empiric antimierobial therapy of nosocomiat pneumonia: the role of the carbapenems. Respir Care, 2004,49 : 1530-1541.
  • 9American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcareassociated pneumonia. Am J Respir Crit Care Med, 2005,171 : 388-416.
  • 10Erdem I, Ozgultekin A, Sengoz Inan A, et al. Incidence, etiology,and antibiotic resistance patterns of gram-negative microorganisms isolated from patients with ventilatorassociated pneumonia in a medical-surgical intensive care unit of a teaching hospital in istanbul, Turkey (2004-2006). Jpn J Infect Dis, 2008,61 : 339-342.

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部